<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01764932</url>
  </required_header>
  <id_info>
    <org_study_id>Advocate-IRB-5242</org_study_id>
    <nct_id>NCT01764932</nct_id>
  </id_info>
  <brief_title>Accuracy of the Thoracic Epidural Catheter Insertion Confirmed by Fluoroscopic Imaging</brief_title>
  <official_title>Determining the Accuracy of Thoracic Epidural Continuous Catheter Insertion With Confirmatory Fluoroscopic Imaging</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chicago Anesthesia Pain Specialists</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chicago Anesthesia Pain Specialists</source>
  <brief_summary>
    <textblock>
      In patients scheduled for thoracic surgery or upper abdominal surgery, investigators will&#xD;
      determine the accuracy of the epidural catheter placement by using fluoroscopic imaging.&#xD;
&#xD;
      Previous studies have drawn contradictory conclusions based the potential flaw assumption of&#xD;
      100% success rate for correct epidural catheter placement in the thoracic region.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Thoracic epidural analgesia (TEA) is a key tool in management of pain after thoracic or upper&#xD;
      abdominal surgery. TEA optimizes pain relief while minimizing the use of systemic opioids,&#xD;
      thus reducing the duration of postoperative ileus. TEA also attenuates surgical stress&#xD;
      response and allows for early mobilization. Despite all the touted benefits of TEA, much&#xD;
      controversy limits its use for post surgical pain due to fear of exceedingly rare, if not&#xD;
      entirely theoretical complication of epidural hematoma.&#xD;
&#xD;
      Beneficial effects of TEA require that catheter placement and infusate be targeted at the&#xD;
      thoracic segments innervating injured skin, muscle, and bone from which pain input&#xD;
      originates. The purpose of this study is to determine the accuracy of thoracic epidural&#xD;
      continuous catheter insertion by using fluoroscopic imaging.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>December 2011</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">November 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Presumed intervertebral level of epidural catheter</measure>
    <time_frame>During procedure</time_frame>
    <description>At the time of thoracic epidural catheter insertion</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Radiologic confirmation of epidural catheter placement</measure>
    <time_frame>Post procedure within one week.</time_frame>
    <description>Radiology department will assess within one week after the procedure the images, to confirm the epidural catheter placement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Numeric Rating Pain Score from baseline</measure>
    <time_frame>1, 24 and 48 hrs</time_frame>
    <description>1, 24, and 48 hrs after the end of the surgery.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Patient satisfaction</measure>
    <time_frame>Post procedure at 48 hours</time_frame>
    <description>Patient satisfaction 48 hrs after the end of surgery</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Patients Undergoing Thoracic Surgery</condition>
  <condition>Patients Undergoing Upper Abdominal Surgery</condition>
  <arm_group>
    <arm_group_label>Thoracic epidural catheter insertion</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Fluoroscopic imaging. For patients undergoing thoracic epidural analgesia (TEA) with catheter placement for pain associated with thoracic or upper abdominal surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Fluoroscopic imaging</intervention_name>
    <description>Contrast media (5 mL) will be injected through the catheter and fluoroscopic images will be obtained and saved in the lateral and antero-posterior projections.</description>
    <arm_group_label>Thoracic epidural catheter insertion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18- 80 years old patients&#xD;
&#xD;
          -  Patients undergoing thoracic surgery&#xD;
&#xD;
          -  Patients undergoing upper abdominal surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Severe Aortic Valve stenosis&#xD;
&#xD;
          -  Active Neurologic Disease&#xD;
&#xD;
          -  Allergy to lidocaine or bupivacaine&#xD;
&#xD;
          -  Allergy to iodine-based contrast&#xD;
&#xD;
          -  Cutaneous Disorders at epidural insertion site&#xD;
&#xD;
          -  Preoperative impaired coagulation status&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kenneth D Candido, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chicago Anesthesia Pain Specialists</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Advocate Illinois Masonic Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60657</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <study_first_submitted>January 2, 2013</study_first_submitted>
  <study_first_submitted_qc>January 8, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 10, 2013</study_first_posted>
  <last_update_submitted>September 13, 2017</last_update_submitted>
  <last_update_submitted_qc>September 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chicago Anesthesia Pain Specialists</investigator_affiliation>
    <investigator_full_name>Kenneth D Candido</investigator_full_name>
    <investigator_title>Chairman of the Anesthesia Department, Advocate Illinois Masonic Medical Center</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm, Dissecting</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

